Skip to main content
SpringerLink
Log in

Pertussis vaccines — 1993

  • Review
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

DTP:

diphtheria, tetanus, pertussis-whole cell vaccine

FHA:

filamentous haemagglutinin

PT:

pertussis toxin

PTr:

recombinant pertussis toxin

References

  1. Ad hoc group for the study of pertussis vaccines (1988) Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events. Lancet 8592: 955–960

    Google Scholar 

  2. American Academy of Pediatrics (1982) Pertussis. In: Report of the committee on infectious diseases, 19th edn. Evanston, pp 198–202

  3. Aoyama T, Murase Y, Kato T, Iwata T (1985) Efficacy of an acellular pertussis vaccine in Japan. J Pediatr 107: 180–183

    PubMed  Google Scholar 

  4. Barkin RM, Pichichero ME (1979) Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics 63:256–260

    PubMed  Google Scholar 

  5. Brennan MJ, Li ZM, Cowell JL, Bisher M, Steven AC, Novotny P, Manclark CR (1988) Identification of a 69 kilodalton nonfimbrial protein as an agglutinogen ofBordetella pertussis. Infect Immun 56:3189–3195

    PubMed  Google Scholar 

  6. Capiau C, Carr SA, Hemling ME, Plainchamp D, Conrath K, Hauser P, Comberbach M, Roelants P, Desmons P, Permanne P, Petre JO (1990) Purification, characterization, and immunological evaluation of the 69 kDa outer membrane protein ofBordetella pertussis. In: Manclark CR (ed) Proceedings of the international symposium on pertussis. Department of Health and Human Services, United States Public Health Service, Bethesda, Maryland (DHHS publication no (FDA) 90-1164: 75–86

    Google Scholar 

  7. CDC (1982) Pertussis surveillance. MMWR 31:333–336

    Google Scholar 

  8. Centers for Disease Control (1982) Pertussis England-Wales. MMWR 31:629–633

    Google Scholar 

  9. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR (1981) Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68:650–660

    PubMed  Google Scholar 

  10. Department of Health and Social Security (1987) Whooping cough: reports from the Committee on Safety of Medicines and the Joint Committee onm Vaccination and Immunization. HMSO London

    Google Scholar 

  11. Edwards KM, Decker MD, Halsey NA, Koblin BA, Townsend T, Auerbach B, Karzon DT (1991) Differences in antibody response to whole-cell pertussis vaccines. Pediatrics 88:1019–1023

    PubMed  Google Scholar 

  12. Ehrengut W (1986) Impfschäden nach Pertussis-Schutzimpfung in der Bundesrepublik Deutschland. Öff Gesundheitswes 48: 123–126

    Google Scholar 

  13. Fine PEM, Clarkson JA (1987) Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 9:866–883

    PubMed  Google Scholar 

  14. Frenkel LD (1986) Pertussis immunization. Pediatr Ann 15: 452–454

    PubMed  Google Scholar 

  15. Granström M, Olinder-Nielsen AM, Holmblad P, Mark A, Hanngren K (1991) Specific immunoglobulin for treatment of whooping cough 338:1230–1233

    Google Scholar 

  16. Hayden GF, Sato PA, Wright PF, Hendersen RH (1989) Progress in worldwide control of disease through immunization. J Pediatr 114:520–527

    PubMed  Google Scholar 

  17. Heininger U, Stehr K, Cherry JD (1992) Serious pertussis overlooked in infants. Eur J Pediatr 151:342–343

    PubMed  Google Scholar 

  18. Immunization Practices Advisory Committee (ACIP) (1992) Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use-supplementary ACIP statement. MMWR 41:1–10

    Google Scholar 

  19. Kanra G, Ceyhan M, Bogaerts H, Vandervoorde D (1992) Acellular pertussis DTP vaccine containing separately purified PT, FHA and 69 kDa OMP as a booster in children. Eur J Pediatr (this issue)

  20. Kulenkampff M, Schwartzman JS, Wilson J (1974) Neurological complications of pertussis inoculation. Arch Dis Child 49:46–49

    PubMed  Google Scholar 

  21. Leininger E, Roberts M, Kenimer JG, Charles IG, Fairweather N, Novotny P, Brennan MJ (1991) Pertactin, an Arg-Gly-Asp containingBordetella pertussis surface protein that promotes adherence of mammalian cell. Proc Natl Acad Sci USA 88: 345–349

    PubMed  Google Scholar 

  22. Miller DL, Ross EM, Alderslade R, Bellman MH, Rawson NSB (1981) Pertussis immunisation and serious acute neurological illness in children. BMJ 282:1595–1599

    PubMed  Google Scholar 

  23. Mortimer EA, Kimura M, Cherry JD, Kuno-Sakai H, Stout MG Dekker CL, Hayashi R, Miyamoto Y, Scott JV, Aoyama T, Isomura S, Iwata T, Kamiya H, Kato T, Noya J, Suzuki E, Takeuchi Y, Yamaoka H (1990) Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following householde exposure of Japanese children. Am J Dis Child 144:899–904

    PubMed  Google Scholar 

  24. Muller AS, Leeuwenburg J, Pratt DS (1986) Pertussis: epidemiology and control. Bull WHO 64:321–331

    PubMed  Google Scholar 

  25. Novotny P, Kobisch M, Cownley K, et al (1985) Evaluation ofBordetella bronchiseptica vaccines in specific pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect Immun 50:190–198

    PubMed  Google Scholar 

  26. Podda A, Nencioni L, Marsili I, Peppoloni S, Volpini G, Donati D, Di Tommaso A, De Magistris MT, Rappuoli R (1991) Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa. Vaccine 9:741–745

    PubMed  Google Scholar 

  27. Podda A, De Luca EC, Titone L, Casadel AM, Cascio A, Peppoloni S, Volpini G, Marsili I, Nencioni N, Rappuoli R (1992) Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12-to 24-and 2-to 4-month-old children. J Pediatr 120: 680–685

    PubMed  Google Scholar 

  28. Shahin RD, Brennan MJ, Li ZM, Meade BD, Manclark CR (1990) Characterization of the protective capacity and immunogenicity of the 69 kD outer membrane protein ofBordetella pertussis. J Exp Med 171: 63–73

    PubMed  Google Scholar 

  29. Storsaeter J, Olin P (1992) Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance. Vaccine 10: 142–144

    PubMed  Google Scholar 

  30. Thomas MG, Redhead K, Lambert HP (1989) Human serum antibody responses toBordetella pertussis infection and pertussis vaccination. J Infect Dis 159: 211–218

    PubMed  Google Scholar 

  31. Wentz KR, Marcuse EK (1991) Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence. Pediatrics 87: 287–297

    PubMed  Google Scholar 

  32. WHO (1987) Six killers of children. World Health 7

  33. Whooping-cough Immunization Committee. Medical Research Council (1959) Vaccination against whooping cough. BMJ 1: 994–1000

    Google Scholar 

  34. Wiedermann G, Ambrosch F, Just M, Vanura H, Berger R, Bogaerts H (1991) Acellular DTP vaccine containing PT and FHA as a primary vaccination: comparison of two doses of PT (abstract). Progr Abstr 31st Intersc Conf Antimcrob Agents Chemother

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Johannes Gutenberg University, Langenbeckstrasse 1, W-6500, Mainz, Germany

    H. -J. Schmitt & S. Wagner

Authors
  1. H. -J. Schmitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmitt, H.J., Wagner, S. Pertussis vaccines — 1993. Eur J Pediatr 152, 462–466 (1993). https://doi.org/10.1007/BF01955049

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01955049

Keywords

Search

Navigation